Laser vs. phenol: which minimally invasive treatment hurts less?
NCT ID NCT07701772
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This trial compares two minimally invasive procedures—laser ablation and crystallized phenol application—for treating primary uncomplicated pilonidal sinus disease. Adults with this condition are randomly assigned to one of the two treatments. The main goal is to measure pain on the first day after the procedure, with additional outcomes including wound healing time and recurrence at six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- laser ablation or crystallized phenol application
- What this could lead to
- If one method proves less painful and faster to heal, it could become the preferred minimally invasive treatment for pilonidal sinus disease.
- What could go wrong
- This is a single-center trial with 120 participants, so results may not apply broadly. Both treatments carry risks of infection or recurrence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PILONIDAL SINUS DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.